Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.4% |
| 2 | Technology | 3.32% |
| 3 | Consumer Discretionary | 2.87% |
| 4 | Financials | 2.84% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Moderna
MRNA
$25.4B
| $3.63M | ﹤0.01% |
56,501
+46,262
| +452% | +$2.53M |
|
3377
Cimpress
CMPR
$2.37B
| $3.63M | ﹤0.01% |
47,505
+5,944
| +14% | +$423K |
|
3378
Nu Skin
NUS
$236M
| $3.62M | ﹤0.01% |
94,741
+62,138
| +191% | +$2M |
|
3379
PUT
Copa Holdings
CPA
$6.17B
| $3.62M | ﹤0.01% |
71,600
+35,400
| +98% | +$1.63M |
|
|
CODX
3380
CALL
Co-Diagnostics
CODX
$5.49M
| $3.62M | ﹤0.01% |
6,233
+1,993
| +47% | +$910K |
|
3381
Sunrun
RUN
$2.37B
| $3.62M | ﹤0.01% |
183,484
-321,506
| -64% | -$4.92M |
|
3382
Conduent
CNDT
$252M
| $3.62M | ﹤0.01% |
1,513,105
+635,688
| +72% | +$1.48M |
|
3383
PUT
Equity Residential
EQR
$24.7B
| $3.61M | ﹤0.01% |
61,400
+37,400
| +156% | +$2.32M |
|
3384
Xtrackers International Real Estate ETF
HAUZ
$1.07B
| $3.6M | ﹤0.01% |
+156,905
| New | +$3.54M |
|
3385
CALL
Murphy Oil
MUR
$4.99B
| $3.6M | ﹤0.01% |
261,000
+64,700
| +33% | +$744K |
|
|
BBT
3386
Beacon Financial Corp
BBT
$2.71B
| $3.6M | ﹤0.01% |
326,640
+212,412
| +186% | +$2.73M |
|
3387
Rexford Industrial Realty
REXR
$8.12B
| $3.6M | ﹤0.01% |
+86,844
| New | +$3.49M |
|
|
PVLA
3388
Palvella Therapeutics
PVLA
$2.26B
| $3.6M | ﹤0.01% |
14,509
-607
| -4% | -$142K |
|
|
BIG
3389
DELISTED
Big Lots, Inc.
BIG
| $3.6M | ﹤0.01% |
85,623
-32,315
| -27% | -$917K |
|
|
MAXR
3390
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $3.6M | ﹤0.01% |
200,300
-84,700
| -30% | -$1.1M |
|
|
GAN
3391
CALL
DELISTED
GAN Ltd
GAN
| $3.59M | ﹤0.01% |
+141,200
| New | +$2.7M |
|
3392
PUT
VICI Properties
VICI
$29B
| $3.59M | ﹤0.01% |
177,900
+116,800
| +191% | +$2.14M |
|
3393
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.3B
| $3.59M | ﹤0.01% |
64,120
-57,684
| -47% | -$3M |
|
3394
PUT
ScottsMiracle-Gro
SMG
$3.59B
| $3.59M | ﹤0.01% |
26,700
+12,400
| +87% | +$1.6M |
|
|
TCDA
3395
DELISTED
Tricida, Inc. Common Stock
TCDA
| $3.59M | ﹤0.01% |
130,647
-31,807
| -20% | -$866K |
|
3396
Phillips 66
PSX
$92.8B
| $3.59M | ﹤0.01% |
49,922
-329,052
| -87% | -$23.3M |
|
3397
Theravance Biopharma
TBPH
$878M
| $3.59M | ﹤0.01% |
170,981
+150,527
| +736% | +$3.87M |
|
|
WRK
3398
PUT
DELISTED
WestRock Company
WRK
| $3.59M | ﹤0.01% |
126,900
+35,800
| +39% | +$1.02M |
|
3399
CALL
Baker Hughes
BKR
$63B
| $3.58M | ﹤0.01% |
232,800
+4,100
| +2% | +$60K |
|
3400
iShares MSCI Kokusai Fund
TOK
$258M
| $3.58M | ﹤0.01% |
51,889
-49,945
| -49% | -$3.24M |
|
Similar funds
Citadel Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.
- Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
- Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.